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Abstract
We earlier showed that 18b-glycyrrhetinic acid (GRA), a pentacyclic triterpenoid from licorice root, could completely cure
visceral leishmaniasis in BALB/c mouse model. This was associated with induction of nitric oxide and proinflammatory
cytokine production through the up regulation of NF-kB. In the present study we tried to decipher the underlying cellular
mechanisms of the curative effect of GRA. Analysis of MAP kinase pathways revealed that GRA caused strong activation of
p38 and to a lesser extent, ERK in bone marrow-derived macrophages (BMDM). Almost complete abrogation of GRA-
induced cytokine production in presence of specific inhibitors of p38 and ERK1/2 confirmed the involvement of these MAP
kinases in GRA-mediated responses. GRA induced mitogen- and stress-activated protein kinase (MSK1) activity in a time-
dependent manner suggested that GRA-mediated NF-kB transactivation is mediated by p38, ERK and MSK1 pathway. As
kinase/phosphatase balance plays an important role in modulating infection, the effect of GRA on MAPK directed
phosphatases (MKP) was studied. GRA markedly reduced the expression and activities of three phosphatases, MKP1, MKP3
and protein phosphatase 2A (PP2A) along with a substantial reduction of p38 and ERK dephosphorylation in infected
BMDM. Similarly in the in vivo situation, GRA treatment of L. donovani-infected BALB/c mice caused marked reduction of
spleen parasite burden associated with concomitant decrease of individual phosphatase levels. However, activation of
kinases also played an important role as the protective effect of GRA was significantly abrogated by pharmacological
inhibition of p38 and ERK pathway. Curative effect of GRA may, therefore, be associated with restoration of proper cellular
kinase/phosphatase balance, rather than modulation of either kinases or phosphatases.
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Introduction
Visceral leishmaniasis (VL), caused by the parasite Leishmania
donovani, is a major health problem with significant morbidity
and mortality worldwide [1]. In order to survive successfully
inside the macrophages, Leishmania employs several strategies
to macrophage defence mechanism which subsequently culmi-
nates in defective immune subvert response [2]. Most of the
drugs used for the therapy of this disease, such as antimonials
as first-line and amphotericin B and pentamidine as second-
line drugs, have serious side effects that limit their clinical
application [3]. Therefore immunomodulators, with our present
day knowledge of the immune system, are creating new
opportunities for the development of immunomodulatory thera-
pies [4,5] in VL.
During the last decade, a large number of dietary components
have been evaluated as potential chemopreventive agents [6].
However, limited scientific evidence regarding the effectiveness of
these natural derivatives, in conjunction with a lack of
mechanistic understanding of their actions, has prevented
their incorporation into the mainstream of medical care. Licorice
(Glycyrrhizza glabra L.) and its main water soluble component 18b-
glycyrrhetinic acid (GRA) have been widely used as a food
flavouring and sweetening agent in diet [7]. GRA has a long
history of medicinal use and is known to exhibit a variety of
pharmacological effects including anti-tumor, anti-hepatotoxic,
and immunomodulatory activities [8–11]. Immunomodulatory
effects of GRA may be mediated by the favourable expression of
nitric oxide (NO) and proinflammatory cytokines from macro-
phages [12–14]. The major transcription factor responsible
for GRA-mediated immunomodulatory effect and NO produc-
tion is NF-kB [12]. We have previously demonstrated that GRA
triggers curative Th1 response and NO up-regulation in
experimental VL by activating NF-kB [15]. But the molecular
signaling pathway, which controls the activation of NF-kB is yet
to be explored.
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A number of studies have indicated that activation of NF-kB
correlates with the increased activation of the mitogen-activated
protein kinase (MAPK) pathway [16,17]. An earlier report shows
that viscerotropic L. donovani parasites fail to induce the activation
of the MAPKs in naive murine bone marrow-derived macro-
phages (BMDM) [18]. L donovani also modulated the TLR2-
stimulated MAPK pathway by suppressing MAPK P38 phosphor-
ylation [19]. Recently we have shown the importance of MEK-
ERK and JAK-STAT signaling pathways in down regulating
Leishmania infection using cystatin as a model anti-leishmanial
compound [20]. A few scattered evidences have also been found in
support of the defective TLR response during Leishmania infection
[21–23]. It is, therefore, quite obvious that MAPK pathway holds
an important role among several other strategies which Leishmania
deploys to undermine host response in order to survive and
replicate within macrophages.
Kinase mediated phosphorylation plays an important role in
macrophage activation, but uncontrolled activation could be
detrimental for the cell. It is necessary for the cells that both the
protein kinases and phosphatases maintain their physiological
balance to sustain a normal regulation of events. Recent studies
have demonstrated that protein phosphatases may serve as pivotal
feedback control regulators in the innate immune response during
Leishmania infection [24,25]. A number of reports have demon-
strated the important role played by SHP-1 in establishing and
augmenting the course of visceral infection [24,26]. SHP-1
dephosphorylates a number of vital kinases and SHP-1-deficient
mice showed a much stronger proinflammatory response against
Leishmania infection compared to wild-type mice. Induction of
SHP-1 by Leishmania is essential for inhibition of NO generation
and this occurs through the inactivation of JAK2 and ERK1/2,
and transcription factors NF-kB and AP-1 [24]. Recently, we have
identified three MAPK directed phosphatases which are upregu-
lated during visceral infection and inhibition of these phosphatases
in L. donovani-infected mice shifted the cytokine balance in favour
of the host [27]. The present study is aimed to uncover the critical
events in the cellular signaling network involving kinase/
phosphatase balance during Leishmania infection by GRA, a
compound of herbal origin, which is safe, nontoxic and therefore
could be used as potential drug for diseases where till date no
satisfactory treatment is available.
Results
Therapeutic effects of GRA through the upregulation of
NO and Th1 cytokines
Treatment of BMDM with GRA resulted in increased iNOS
mRNA expression in a dose- and time-dependent manner
(Figure 1A). Maximum expression (14.4-fold) was obtained at
24 h with 20 mM GRA. Maximum nitrite production
(10.4 nmol/106 cells) as well as maximum inhibition of
intracellular amastigote count (91.3% suppression) was also
observed in cells treated with 20 mM GRA for 24 h
(Figure 1D). In vivo administration of GRA resulted in much
higher NO generation and antileishmanial activity. Peritoneal
macrophages from GRA (50 mg/kg/day)-administered mice
exhibited 22.861.6 nmol/106 cells of NO2
2 and 97.7% parasite
suppression compared to 10.4 nmol/106 cells of NO2
2 and
91.3% suppression from their in vitro counterpart (Figure 1E).
Nitrite production as well as antileishmanial activity of both
in vitro and ex vivo effects of GRA were significantly abrograted
by 2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine (AMT), an
inhibitor of iNOS, suggesting that the antileishmanial effect of
GRA may be correlated with increased production of NO
(Figure 1D and 1E). GRA treatment of L. donovani-infected
BMDM potentiated Th1 type immunity, evident from a
significant rise in IL-12 (5.2-fold), TNF-a (5.8-fold) and IL-1b
(3.56 fold) production with concomitant decrease of IL-10 (78%)
and TGF-b (75%), signature Th2 cytokines, compared to infected
BMDM (Figure 1F and G). However, the level of IL-6, which
was increased after Leishmania infection, was not altered by GRA
treatment (Figure 1G). This is not surprising as IL-6 has been
reported to exert an early, suppressive effect on host defense by
restraining Th1-cell-type antileishmanial responses [28]. When
tested in a mouse model of VL, a dose of 50 mg/kg/day given
i.p. 3 times 5 days apart starting at 10 days after infection resulted
in possibly complete elimination of spleen parasite burden
(Figure 1H) at 6 wk after infection. Absence of parasites in the
spleen of treated animals was further confirmed by culturing
spleen specimens in transformation medium for 4 days at 22uC
and limiting dilution assay for 2-wk and 6-wk sample (Figure 1I).
The protective effect of GRA was documented by reinfecting
cured animals 8 wk after infection (data not shown). Very little
increase in the spleen parasite burden suggested that along with
macrophage activating immunomodulatory properties, GRA also
imparted significant protection against further infection.
GRA activates NF-kB cascade in L. donovani infected
mouse spleen
We earlier demonstrated that in cultured macrophages, GRA
activates NF-kB signaling pathway at some level upstream of IKK
[15]. In the present study, these experiments were done in primary
cells (mouse BMDM), which might be more relevant cellular
context to parallel murine model of visceral leishmaniasis.
Induction of IKK/NF-kB activation is also operative in primary
cells like BMDM as reflected in the nuclear translocation of NF-kB
p65 subunit judged by fluorescence microscopy. In unstimulated
and L. donovani-infected macrophages, the signal for p65 was
distributed throughout the cell but did not colocalize with DAPI-
stained nuclei indicating its cytosolic localization (Figure 2A). On
the contrary, GRA stimulation resulted in induction in the nuclear
import of p65 as evident by pronouncedly enhanced nuclear
colocalization within 2 h of treatment (Figure 2A). In order to
ascertain its status in vivo, we examined the relative abundance,
subcellular distribution and functional activity of NF-kB in
infected mice. A curative dose of 50 mg/kg/day of GRA were
given 3 times 5 days apart starting at 10 days after infection and
splenocytes were isolated 3 days after the final treatment. Binding
to oligonucleotides containing a consensus NF-kB response
element was markedly increased (5.4-fold) in GRA-treated infected
mice compared to infected control (Figure 2B). To identify the
specific NF-kB subunits that comprise the NF-kB signal detected
by EMSA, supershift assay was performed with specific antibodies
against p50, p52, p65, c-Rel and Rel B. Both p65 and p50
antibodies caused a significant shift of the entire signal, whereas
anti-p52, and anti-c-Rel and anti-Rel B antibodies did not have
any effect (Figure 2C). Western blot analysis of the cytoplasmic
extract prepared from splenocytes revealed that IkBa protein
levels were greatly depleted (95.1%) in GRA-treated infected
animals indicating that NF-kB activation occurred via IkBa
degradation (Figure 2D). Since IkBa is thought to be
phosphorylated by the IKKb component of the IKK multiprotein
complex, IKKb was immunoprecipitated from splenocytes and
tested for the ability to phosphorylate GST-IkBa substrate. As
shown in Figure 2E, GRA treatment strongly induced IKKb
activity (6.25-fold) in the spleen of infected mice. Western blotting
for IKKb was performed as a loading control and showed that
similar amounts of IKKb were immunoprecipitated from the
18b-Glycyrrhetinic Acid in Leishmaniasis
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splenocyte extracts. All these results suggest that activation of NF-
kB is induced in the spleen of L. donovani-infected mice by
treatment with GRA. In order to ascertain whether the induction
of NF-kB activation was directly correlated with the therapeutic
effect of GRA, we used BAY 11-7085, which is known to attenuate
both the phosphorylation of IkBa and NF-kB activity in vivo [29].
As shown in Figure 2F, a dose of 5 mg/kg/day of BAY 11-7085
given 3 times weekly for 4 wk starting at 2 wk after infection could
significantly reverse GRA-mediated suppression of spleen parasite
burden (70.2% reduction) and GRA-mediated increase of iNOS
(71.7% reduction) (Figure 2G) and TNF-a (77.6% reduction)
(Figure 2H) expression, as revealed by Real time PCR analysis,
stressing further that the therapeutic effect of GRA may be
attributed to the activation of NF-kB pathway in L. donovani-
infected mice.
GRA activates MAPK pathways
To understand the molecular mechanism of GRA-mediated
activation of macrophages, next we investigated the MAPK
signaling pathways, which are known to play a major role in iNOS
and pro-inflammatory cytokine production. Kinetic study with
BMDM showed that GRA (20 mM) markedly induced the
phosphorylation of p38 at 2 h, and the level remained elevated
as studied up to 4 h (Figure 3A). GRA also activated ERK1/2,
although to a lesser extent as compared to p38, but no induction of
p46 and p54 JNK was observed (Figure 3A). Kinetic analysis of
GRA-treated infected macrophages showed similar pattern with
lesser induction and slower kinetics in infected cells (Figure 3B).
Preincubation of cells for 1 h before GRA stimulation with specific
p38 and ERK1/2 inhibitors, SB203580 and apigenin, resulted in
dose-dependent reduction of iNOS mRNA expression. A
Figure 1. Antileishmanial activity of GRA. (A) Dose- and time-dependent expression of iNOS by Taqman analysis of the mRNA transcript in
BMDM stimulated with GRA. mRNA levels were normalized to b-actin and expressed as a -fold change compared with control. (B) Percentages of
infected cells and (C) number of parasites per macrophage were counted at various time periods following infection. (D) Effect of GRA on NO
production (solid bar) and parasite suppression (open bar) in BMDM in presence or absence of AMT (10 mM). (E) Generation of NO (solid bar) and
parasite suppression (open bar) in peritoneal macrophages isolated from mice which received GRA (10, 50 and 100 mg/kg) i.p. for 3 times 5 days
apart. Macrophages were harvested 10 h after the last injection and infected with L. donovani. After 4 h infection and 20 h of incubation, the
percentage of parasite suppression and the amount of NO2
2 in the medium were determined. (F) and (G) Levels of IL-12, TNF-a, IL-10 ,TGF-b, IL-6 and
IL-1b in culture supernatants from infected and GRA (20 mM)-treated BMDM were determined by ELISA. (H) Mice were administered i.v. with 107
promastigotes, and after 10 days of infection, were treated with GRA (25 or 50/mg/kg) i.p. 3 times 5 days apart. Spleen parasite burdens were
determined 6 wk after infection and are expressed as LDU 6 SD. (I) Spleen parasite burden determined 2 and 6 wk following infection measured by
limiting dilution assay expressed as log10 parasite burden6 SD. Cultures were set in triplicate and experiments were done a minimum of three times.
Animal experiments were done with five animals/group and the results are representative of three independent experiments. Data represent the
mean 6 SD. ***p,0.001; Student’s t-test.
doi:10.1371/journal.pone.0029062.g001
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maximum reduction of 64.2% and 44.1% was obtained at the
highest concentration of SB203580 (30 mM) and apigenin (40 mM)
respectively (Figure 3C). Whereas the selective blockage of the
p38 pathway markedly inhibited GRA-induced IL-12 and TNF-a
expression (71.1% and 73.9% respectively), the effect was minimal
in case of ERK1/2 inhibitor (32.9% and 28.8% respectively)
(Figure 3D). The role of p38 therefore is probably more
important in the modulation of GRA-mediated Th1 response.
Next we wanted to determine whether NF-kB activation was also
under the control of this signaling cascade. Cell exposure to
SB203580 resulted in significant decrease (68.2%) of GRA-
inducible NF-kB luciferase reporter activity, but a lesser decrease
(32.1%) was found in case of apigenin (40 mM) (Figure 3E).
However, a combination of both inhibitors greatly inhibited
luciferase gene expression (87.1%) (Figure 3E), suggesting that
ERK and p38 MAPK activation are critical in sustaining GRA
mediated NF-kB activation. This observation prompted us to
investigate the role of MSK1, which is a downstream target of
both p38 and ERK and phosphorylates transcription factors.
These two MAPKs are reported to activate MSK1 in inflamma-
tory conditions in cell lines like HEK293 and L929sA [30]. GRA
could markedly activate MSK1 activity, which was partially
inhibited by pretreatment with either SB203580 (59.2% reduction)
or apigenin (44.1% reduction) (Figure 3F). A combination of both
greatly reduced (86.1%) MSK1 activation suggesting that p38
MAPK and ERK act synergistically to activate MSK1
(Figure 3F). Taken together, these results suggest that p38/
MSK1 and ERK1/2/MSK1-mediated NF-kB activation are
necessary for the induction of iNOS and Th1 cytokine expression
in response to GRA.
GRA negatively regulates expression of MAPK directed
phosphatases
Macrophage’s signal transduction mechanisms are usually
triggered through a series of kinases by protein phosphorylation
during infection and are generally counter regulated by various
Figure 2. Involvement of NF-kB in GRA-mediated anti-leishmanial response. (A) L. donovani-infected and GRA (20 mM)-treated BMDM were
stained with anti-p65 monoclonal antibody and APC-conjugated secondary antibody. Nuclei were stained with DAPI and cells were analyzed under
fluorescence microscope as described in Materials and Methods. (B and C) L. donovani-infected mice were treated with GRA (50 mg/kg) for 3 times 5
days apart starting at 10 days after infection and splenocytes were isolated 3 days after last treatment. Labeled NF-kB probe was incubated with
nuclear extracts of splenocytes and EMSA was performed (B). The bands were analyzed densitometrically and –fold changes are indicated. (C) For
supershift assay, nuclear extracts from splenocytes were incubated with antibodies against individual components of NF-kB complex for 30 min. The
results are representative of one of three separate experiments. (D) Western blot analysis shows a depletion of IkBa protein in splenocytes of GRA-
treated mice as opposed to increased preservation in infected group. (E) IKKb was immunoprecipitated from splenocyte cell lysate and IKK activity
was assayed using GST-IkBa as substrate, and GST-phosphorylated IkBa was visualized by autoradiography. Relative amount of IKKb was determined
by Western blots. L. donovani-infected mice were treated either with GRA (50 mg/kg) as described in the legend of Figure 1E or with GRA plus
BAY11-7085 (5 mg/kg/day) 3 times weekly for 4 wk starting at 2 wk after infection. Parasite burden in spleen (F) mRNA expression of iNOS (G) and
the level of TNF-a (H) in the splenocytes were determined. Results are representative of three individual experiments and the error bars represent
mean 6 SD (n = 3). ***p,0.001; Student’s t-test.
doi:10.1371/journal.pone.0029062.g002
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phosphatases, unfortunately sometimes manipulated by the
invading pathogens. To understand whether MAP kinase
activation by GRA could be an after-effect of down regulation
of phosphatase activity, we first checked the total PTP activity in
infected and infected GRA-treated macrophages. L. donovani
infection induced a time dependent increase in PTP activity
(4.5-fold at 2 h after infection), which was significantly decreased
by GRA treatment (maximum reduction of 75.8% at 4 h)
(Figure 4A). We then concentrated on the effect of GRA on
MAPK directed phosphatases. We have recently documented that
three MAPK directed phosphatases, namely MKP1, MKP3 and
PP2A play a significant role in visceral infection by augmenting
disease progressing Th2 cytokine response [27]. Real time PCR
analysis with Taqman probes in L. donovani-infected BMMs
showed a significant rise in the expression of all three phosphatases
(7.6, 6.6- and 6.3-fold increase for MKP1, MKP3 and PP2A
Figure 3. Effect of GRA on the regulation of iNOS and Th1 cytokine by MAPK activation. (A) BMDM were treated with GRA (20 mM) for
different time periods. The expression and phosphorylation of MAPKs were detected by Western blotting. (B) L. donovani-infected BMDM were
treated with GRA (20 mM) for various time periods and the level of phosphorylated p38 was measured by Western blotting. (C and D) BMDM were
treated (1 h) with either SB203580 (30 mM) or apigenin (40 mM) or both before stimulation with GRA (24 h). iNOS expression (C) by Taqman analysis
and levels of IL-12 and TNF-a (D) by ELISA were determined. (E) RAW 264.7 cells were transiently transfected using Lipofectamine reagent with 1 mg
of NF-kB luciferase reporter vector along with 0.5 mg pcMV-bgal. After 24 h, cells were stimulated with GRA (20 mM) for different time periods. In a
separate set of experiment, transfected cells were pre-incubated with either SB203580 (30 mM) or apigenin (40 mM) or both for 1 h before stimulation
with GRA (12 h). Cells were lysed and processed for luciferase activity. (F) BMDM were treated with GRA (20 mM) for different time periods or pre-
incubated with either SB203580 (30 mM) or apigenin (40 mM) or both for 1 h before stimulation with GRA (2 h). Cell lysates were then
immunoprecipitated with anti-MSK1 Ab and MSK1 activity was assayed using CREBTIDE as substrate. Bands were analyzed densitometrically. Error
bars represent mean 6 SD (n = 3). The data shown are representative of three independent experiments. ns, not significant; *p,0.05, **p,0.01,
***p,0.001; Student’s t-test.
doi:10.1371/journal.pone.0029062.g003
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respectively) compared to control at 2 h post infection (Figure 4B
and 4C). On the contrary, treatment with GRA caused a
significant decrease in the expression of all three phosphatases at
both mRNA (76.2%, 71.9% and 66.8% decrease for MKP1,
MKP3 and PP2A respectively) (Figure 4B and 4C) and protein
(67.6%, 72.1% and 74.2% decrease for MKP1, MKP3 and PP2A
respectively) level at 4 h after treatment (Figure 4E). Unlike these
phosphatases, the expression of SHP-1 remained unchanged both
at mRNA and protein level after L.donovani infection (Figure 4D
and 4F), but its activity was increased as evidenced by
dephosphorylation assay. To ascertain whether GRA could
modulate the infection-induced activation of phosphatases, their
activities were assayed using recombinant p-ERK and p-p38
substrates. Dephosphorylation of substrates demonstrated that
among the infection-induced phosphatases, pERK serves a better
substrate for SHP-1, MKP3 and PP2A (58.6%, 68.3% and 77.9%
decrease in phosphorylation for SHP-1, MKP3 and PP2A
respectively) (Figure 4G and 4H) whereas MKP1 has a
preference for p-p38 (60.2% decrease in phosphorylation for
MKP1) (Figure 4G and 4I). As expected, all phosphatases from
GRA-treated infected macrophages showed much lesser dephos-
phorylating activity towards recombinant substrates (8.6%, 2.6%,
and 27.1% decrease of ERK phosphorylation for SHP-1, MKP3
and PP2A respectively and 5% decrease of p38 phosphorylation
by MKP1) (Figure 4G, 4H and 4I). Therefore, decrease in the
phosphatase activity significantly contributes in GRA-mediated
MAPK activation.
GRA modulates kinase/phosphatase balance in infected
mice
In order to ascertain the role of GRA on cellular kinase/
phosphatase balance in vivo, GRA (50 mg/kg/day) was adminis-
tered i.p. in L. donovani-infected mice for 3 times 5 days apart
starting at 10 days post-infection and splenocytes were isolated. To
gain insight into the effect of p38 and ERK pathways in GRA-
mediated curative response, separate groups of infected mice were
treated with p38 inhibitor SB203580-HCL (10 mg/kg; twice
weekly) or ERK-inhibitor PD0325901 (20 mg/kg; twice weekly)
over a 4-wk period along with GRA. In all the four groups
(infected, infected GRA-treated, infected GRA-treated as well as
p38 inhibitor-treated and infected GRA-treated as well as ERK1/
2 inhibitor-treated), spleen parasite burden and phosphatase
(MKP1, MKP3 and PP2A) activities were measured. Similar to
the in vitro scenario, in infected animals, activities of all three
phosphatases were elevated, being maximum at 2 wk for MKPs
(4.9-fold for MKP1 and 4.3-fold for MKP3) and at 3 wk for PP2A
(5.4-fold). For all three phosphatases, enzymatic activity was found
to be elevated as studied up to 6 wk of infection (Figure 5C, 5D
and 5E). On the contrary, GRA-treated mice showed almost
complete suppression of spleen parasite burden at 6 wk
(Figure 5A and 5B) along with a substantial decrease of
MKP1 (75.4%), MKP3 (68.2%) and PP2A (69.3%) activities
(Figure 5C, 5D and 5E). GRA-mediated suppression of spleen
parasite burden was significantly reversed in p38 inhibitor-treated
mice whereas the effect was much less in ERK inhibitor-treated
animals (Figure 5A and 5B). Interestingly, in vivo pharmacologic
inhibition of p38 and ERK pathway could not alter GRA-
mediated inhibition of phosphatase activities, which suggested that
GRA-mediated anti-leishmanial effect is dependent on both kinase
and phosphatase activities. Down regulation of phosphatase
activity alone is not enough to vouch for GRA’s immunomodu-
latory property. To further substantiate the importance of MAPK
pathway in GRA-mediated curative effect, we checked whether
GRA-mediated modulation of pro/anti-inflammatory balance
Figure 4. Effect of GRA on cellular kinase/phosphatase balance. BMDM were infected with L. donovani promastigotes and treated with GRA
(20 mM) for various time periods. (A) Induction of PTP activity was measured using a PTP assay kit. Results are expressed as the relative increase (n-
fold) over PTP activity in control cells. Expression of MKP1, MKP3 (B), PP2A (C) and SHP-1 (D) at mRNA and at protein level (E and F) were determined
by Real time PCR and immunoblot analysis respectively. SHP-1, MKP1, MKP3 and PP2A were immunoprecipitated from infected and GRA (20 mM, 4 h)-
treated macrophages and assayed for dephosphorylation activity using either recombinant p-ERK or p-p38 as substrate and visualizing by
immunoblotting with anti-p-ERK (G and H) and anti-p-p38 (I) antibody. The amount of individual phosphatases was measured by stripping the blot
and reprobing with antibodies against SHP-1, MKP1, MKP3 or PP2A. Results are representative of three individual experiments. Data represent the
mean 6 SD, n = 3. ***p,0.001; Student’s t-test.
doi:10.1371/journal.pone.0029062.g004
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were altered in presence of MAPK inhibitors. GRA treatment
resulted in increased mRNA expression of TNF-a (8.9-fold)
(Figure 5F) along with a concomitant decrease (74.1%) in IL-10
expression (Figure 5G) in infected animals at 4 wk. On the
contrary, administration of p38 inhibitor markedly attenuated
GRA-induced TNF-a expression (73.1%) along with reversal of
GRA-mediated suppression of IL-10 (23.2%) expression. More-
over, in vivo DNA binding activity of NF-kB in GRA-treated
infected animal was significantly reduced in presence of p38
inhibitor although to a much lesser extent in ERK inhibitor
treated animals (Figure 5H). These results clearly demonstrate
that i) p38 MAPK activation plays a predominant role in GRA-
mediated in vivo activation of NF-kB as well as antileishmanial
effector response and ii) kinase/phosphatase balance is vital for
intracellular infection and GRA could modulate this balance in
favour of the host.
Discussion
In the susceptible host, control of visceral leishmaniasis revolves
around the state of activation of the tissue mononuclear
phagocytes. Unstimulated resident macrophages of liver, spleen
and bone marrow, the target cells of this disseminated intracellular
infection, initially support parasite replication. However, if
appropriately activated, the same macrophages and tissue-homing
blood monocytes develop sufficient leishmanicidal activity to
control and largely resolve the infection [31]. Immunomodulators
are becoming popular as promising alternative to traditional
medicine because they play a particularly prominent macrophage-
activating role, which extends to the priming of macrophages to
secrete leishmanicidal molecules that include iNOS-derived
reactive nitrogen intermediates and proinflammatory cytokines
[32]. GRA is one such immunomodulator of herbal origin as it is
known to stimulate macrophage-derived NO production, and is
able to upregulate iNOS expression through NF-kB transactiva-
tion in murine macrophages [12]. Previously we documented that
GRA has strong potential to be used as a potent antileishmanial
agent and this effect could be attributed to the NF-kB up-
regulatory property of GRA [15]. In the present work, we tried to
elucidate the intracellular signaling mechanism of GRA respon-
sible for its antileishmanial effect. We found that amongst three
major MAP kinases responsible for proinflammatory cytokine
production, p38 MAPK primarily and to a lesser extent ERK
contribute in GRA- mediated activation of NF-kB as well as anti-
leishmanial cellular and immunological response. Interestingly,
GRA-mediated MAPK activation could be an after effect of down
regulation of MAPK directed phosphatases, which are activated
during infection. Therefore, GRA might exert its immunomodu-
latory effect by modulating cellular kinase/phosphatase balance,
which often plays a very important role in dictating the fate of
intracellular infection [33].
The importance of NF-kB in resistance to Leishmania infection
has been clearly established by studies in which mice deficient in
different NF-kB family members were shown to be susceptible to
parasitic infections [34]. We first demonstrated that, as an efficient
immunomodulator, GRA activated NF-kB pathway in parasite-
Figure 5. Effect of GRA on in vivo kinase/phosphatases balance, modulation of parasitemia and cytokine response. L. donovani-
infected mice was treated with GRA (50 mg/kg) i.p. for 3 times 5 days apart starting at 10 days post-infection. In a separate group, infected mice were
treated with either p38 inhibitor SB203580-HCL (10 mg/kg) or ERK-inhibitor PD0325901 (20 mg/kg) over a 4 wk period along with GRA. (A) Spleen
parasite burdens were determined weekly in each group and expressed as LDU 6 SD. (B) Spleen parasite burden determined 2 and 6 wk following
infection measured by limiting dilution assay expressed as log10 parasite burden 6 SD. MKP1, MKP3 and PP2A were immunoprecipitated from cell
lysates of splenocytes isolated from different experimental groups with respective antibodies. MKP1 (C) and MKP3 (D) and PP2A (E) activity was
assayed by pNPP hydrolysis and assay kit respectively. Expression of TNF-a (F) and IL-10 (G) at mRNA level were determined by Real time PCR in the
splenocytes. (H) NF-kB DNA binding activity was determined in the splenocytes of different experimental groups as described in the legend of
Figure 1B. Animal experiments were done with five animals/group and the results are representative of three individual experiments. ns, not
significant; **p,0.01, ***p,0.001; Student’s t-test.
doi:10.1371/journal.pone.0029062.g005
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infected BALB/c mice. The most prevalent activated form p65
and p50 contribute mainly in GRA- mediated activation of NF-kB
in in vivo. Furthermore, the results provide the first in vivo evidence
that GRA may exert its curative effects on experimental visceral
leishmaniasis mostly through its ability to activate NF-kB by
inducing phosphorylation and subsequent degradation of IkBa.
Using pharmacologic inhibitor NF-kB, we also demonstrated that
activation of NF-kB is absolutely essential for GRA-mediated
suppression of spleen parasite burden and induction of proin-
flammatory gene expression.
As MAPK pathways play a major role in proinflammatory
cytokine synthesis, rigid control mechanisms exist to prevent
inappropriate activation, which could be detrimental for the cell.
On the other hand, some opportunistic pathogens like Leishmania
take advantage of this regulation and use the system in favour of
their own survival within macrophages. Studies revealed that
Leishmania impair the CD40 effector functions by interrupting the
CD40 signaling through p38 MAPK in macrophages [35]. NO
production and killing of L. donavani parasite in infected
macrophages in response to sodium antimony gluconate treatment
involved mainly PI3K and p38 MAPK [36] and activation of p38
MAPK has also been shown to play an important role in
eliminating L. donovani infection [37]. All these studies suggest that
compounds having ability of augmenting signaling pathways
leading to macrophage activation might demonstrate protective
action against Leishmania infection. In the present study GRA
enhanced NF-kB activity at both in vitro and in vivo situation which
was found to be mainly under the control of the p38 pathway and
to a lesser extent ERK1/2 pathway. Direct correlation between
MAPK activation and upregulation of both NF-kB activity and
NO production has been shown in a number of studies [16,17,20].
A growing body of evidences indicate that MSK1, a nuclear kinase
downstream of both ERK1/2 and p38 and might therefore be an
end-kinase in the inflammatory process involving NF-kB, act as a
post-translational modifier of NF-kB by inducing phosphorylation
of p65 subunit at Ser276 residue [30]. The present study revealed
that GRA could also activate MSK1 in BMDM that was under the
control of ERK1/2 and p38 as pharmacologic inhibition of both
these MAPKs markedly attenuated GRA-induced MSK1 activity.
Activation of MAPKs are tightly regulated in phagocytic cells by
counteracting protein phosphatases and we have recently
demonstrated that MAPK directed phosphatases play a crucial
role in disease progression of visceral leishmaniasis by modulating
pro/anti-inflammatory cytokine balance [27]. The role of SHP-1
in modulating visceral infection has already been documented
[24,26]. It is possible that MAPK activation by GRA could be an
after-effect of down regulation of all these phosphatases. Selective
dephosphorylation of recombinant p38 and ERK substrate in L.
donovani-infected macrophages were markedly attenuated by GRA,
which may be associated with down-regulation of MKP1, MKP3
and PP2A expression. A different scenario was obtained for SHP-
1, where L. donovani infection only increased the activity without
altering its expression level. GRA treatment decreased the activity
of SHP-1 as evidenced by ERK dephosphorylation assay. p38, the
major MAPK activated by GRA, was not regulated by SHP-1,
which is in accordance with previous reportss [38]. In the in vivo
situation also, GRA treatment markedly abrogated MKP1, MKP3
and PP2A activity in L. donovani-infected mice. Interestingly,
although in vivo blockage of p38 and ERK pathway could not alter
GRA-mediated inhibition of phosphatase activities but these could
reverse GRA-induced suppression of spleen parasite burden and
IL-10 synthesis as well as induction of TNF-a synthesis.
Regulation of either kinases or phosphatases by GRA is not the
deciding factor for the outcome of infection in VL. It is the overall
shifting of kinase/phosphatases balance towards kinases, which is
important to exert curative responses by GRA.
GRA, therefore, could be a new class of macrophage activators
to stimulate the induction of iNOS and pro-inflammatory
cytokines. It is used as a natural food ingredient and as flavouring
and sweetening agent in food products. It has also been widely
used as an antidote, demulcent and as a folk medicine for
generations in Asia and Europe. A dose of 50 mg/kg body weight
of GRA could completely eliminate the spleen parasite burden in
experimental mouse model of VL. In extrapolating this dose to an
80-kg human with a surface area of 2 m2 (Costeff’s rule), it would
take a total dose of 4 g (50 mg680) or 2 g/m2 of surface area,
which is within the nontoxic consumption limit of GRA [39].
Overall, a comprehensive understanding of the detailed upstream
signaling events by which GRA triggers curative response against
experimental visceral leishmaniasis could better define its potential
as an effective immunomodulator not only for non healing
leishmaniasis but also for other chronic diseases.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Committee on the Ethics of Animal
Experiments of Indian Institute of Chemical Biology (Permit
Number: 147-1999).
Parasites, cell culture, NO production and infection
L. donovani promastigotes ((MHOM/IN/1983/AG83) were
grown as described earlier [40]. Peritoneal macrophages and
BMDM from BALB/c mice were isolated and maintained as
described earlier [15,27]. For BMDM, bone marrow cells were
isolated from the femurs and tibias of 6–8 wk old BALB/c mice
and were suspended in RPMI 1640 supplemented with 100 U/ml
penicillin and 100 mg/ml streptomycin, 10% FCS, 5% horse
serum, and 20% L929-conditioned media and were incubated at
5% CO2, 95% humidity, at 37uC. On the 4th day, cells were fed
again with L-cell conditioned medium; on day 6, cells were
harvested, counted and used for experiments. Splenocytes were
cultured as described previously [40]. In vitro infection experiments
were carried out at a 10:1 parasite/cell ratio as described earlier
[27]. The numbers of infected macrophages (% of infection) and
parasite burden (number of parasites per infected macrophages)
were determined by counting 200 macrophages. Nitrite formation
in macrophage culture supernatants was detected by the Griess
reaction as previously described [15]. For in vivo experiments,
female BALB/c mice were injected via the tail vein with 107 L.
donovani promastigotes. For reinfection experiments, promastigotes
were injected 8 wk after the first infection. GRA (Sigma Aldrich)
(10–100 mg/kg/day) was administered i.p. for 3 times 5 days
apart starting at 10 days post-infection. Infection was assessed by
removing spleen from infected mice at different time periods and
parasite burdens were determined from Giemsa-stained impres-
sion smears. Data are presented as Leishman–Donovan units
(LDU) [41]. To further ascertain whether the spleen contained live
parasites, in selected experiments, the parasite burden in spleen
was also quantified by limiting dilution technique according to
Banerjee et al. [42]. In brief, a measured amount of spleen was
homogenized in Schneider’s medium (Invitrogen) supplemented
with 10% FCS and diluted to a final concentration of 1 mg/ml.
This was then serially diluted up to five fold and cultured at 22uC
for 14 days. Reciprocal of the highest dilution positive for live
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parasites was considered to be the concentration of parasites per
milligram of spleen and spleen parasite burden was calculated
from the total weight of the spleen.
Real-time PCR
Total RNA from cells was isolated using the RNeasy mini kit
(Qiagen) according to the manufacturer’s instructions. cDNA was
synthesized from 1 mg of DNA using the SuperScript first strand
synthesis system for the RT-PCR kit (Invitrogen). TaqMan probes
for IL-12, TNF-a and iNOS were purchased from Applied
Biosystems. Quantitative real-time PCRs were performed in the
ABI 7500 Fast Sequence detector with the following PCR
amplification conditions: 40 cycles of 95uC for 15 s and 60uC
for 1 min. Relative quantitation was performed using the
comparative DDCt method and data was normalized to mouse
b-actin mRNA levels and expressed as a –fold change compared to
uninfected controls.
Western Blotting and ELISA
Immunoblotting was performed as previously described [15,27].
Densitometric analyses for all experiments were carried out using
QUANTITY ONE software (Bio-Rad). Band intensities for
immunoblots were normalized to b-actin and expressed in
arbitrary units. For ELISA, the level of various cytokines in the
culture supernatants were measured using a sandwich ELISA kit
(Quantikine M, R&D Systems) as per the detailed instructions of
the manufacturer.
MSK1 activity assay
MSK1 assay was performed as described previously [20].
Briefly, treated macrophages were washed with ice-cold PBS and
lysed in lysis buffer containing 50 mM Tris-HCl, pH 7.5, 1 mM
EDTA, 1 mM EGTA, 1 mM sodium orthovanadate, 1% (v/v)
Triton X-100, 50 mM NaF, 5 mM sodium pyrophosphate,
0.27 M sucrose, 0.1%(v/v) b mercaptoethanol, 1 mM benzami-
dine, 2 mg/ml leupeptin, and 0.2 mM pefabloc. Whole cell lysates
(1 mg) collected by centrifugation (5 min, 10,0006 g, 4uC), were
immunoprecipitated with 2 mg of anti-MSK1 Ab for 2 h at 4uC.
Protein G–agarose was added and further incubated for 2 h. After
centrifugation, the pellets were washed twice with cell lysis buffer
and twice with kinase assay buffer (Cell Signaling Technology).
Immunoprecipitated MSK1 pellets were incubated at 30uC for
30 min in 50 ml of kinase buffer containing 30 mM substrate
peptide: EILSRRPSYRK (CREBTIDE) and 0.1 mM [c32P] ATP
(200,000 cpm/pmol). Reactions were stopped by placing the tubes
on ice. After centrifugation (30 s, 4uC, 100006 g), 30 ml of
supernatant was spotted on p81 phosphocellulose paper, washed
thrice with 0.75 M orthophosphoric acid and incorporation of
radiolabelled phosphates in CREBTIDE was determined.
IkB kinase b (IKKb) assay
IKKb assay was performed as described earlier [20]. Subcel-
lular protein fractions were prepared from freshly isolated spleen
in cold kinase assay lysis buffer (20 mM Tris-HCl, pH 8.0,
500 mM NaCl, 1 mM EDTA, 1 mM EGTA, 10 mM b-
glycerophosphate, 10 mM NaF, 10 mM pNPP, 300 mM Na3VO4,
1 mM benzamidine, 2 mM PMSF, 10 mg/ml aprotinin, 1 mg/ml
leupeptin, 1 mg/ml pepstatin, 1 mM DTT and 0.25% Nonidet P-
40) for IKK activity. The IKK activity was measured as described
earlier with slight modification [15]. Briefly, the cell lysates
(500 mg) were immunoprecipitated with anti-IKKb Ab in
immunoprecipitation buffer [25] and immunoprecipitated samples
were incubated with recombinant IkBa (4 mg) in kinase buffer
(Cell Signaling Technology) at 30uC for 1 h. The kinase reaction
was stopped by addition of SDS-sample buffer. The sample was
resolved by SDS-PAGE, dried and autoradiographed. To
determine the total amount of IKKb in each sample, 30 mg of
the whole cell extract protein was subjected to SDS-PAGE and
analyzed by Western blot using anti-IKKb Ab.
Electrophoretic mobility shift assay (EMSA)
EMSA was performed in isolated splenocytes as described
earlier [20]. Briefly, isolated spleen cells were resuspended in
hypotonic buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl2,
10 mM KCl, 0.2 mM PMSF and 0.5 mM DTT), and allowed
to swell on ice for 10 min and treated with 1% NP-40. Cells were
homogenized in a Dounce homogenizer. The nuclei were
separated by spinning at 3,3006 g for 5 min at 4uC. The nuclear
pellet was extracted in nuclear extraction buffer (20 mM HEPES,
pH 7.9, 0.4 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 25%
glycerol, 0.5 mM PMSF and 0.5 mM DTT) for 30 min on ice,
and centrifuged at 12,0006g for 30 min. Supernatants containing
the nuclear extract were collected and used for EMSA. For the
preparation of radiolabeled probes representing standard consen-
sus sequences of NF-kB, the following oligonucleotides were used:
59-AGT TGA GGG GAC TTT CCC AGG C-39. As a control, a
100-fold molar excess of unlabelled competitor oligonucleotide
was added. For supershift assay, the nuclear extracts were
incubated with Ab against individual components of NF-kB
complex (Santa Cruz Biotechnology) for 30 min at 25uC and
analyzed by EMSA in the presence of all components of the
binding reaction described earlier [15].
Transient transfection and reporter assay
Transfections and NF-kB luciferase activity were performed as
described previously [20]. Transfections were carried out in 26106
cells with the appropriate constructs in serum free medium using
Lipofectamine (Invitrogen Life Technologies) according to the
manufacturers’ instruction. Three hour after transfection, the cells
were washed and replaced with RPMI medium containing 10%
FCS. After 24 h, cells were processed as indicated in figure legend.
For NF-kB luciferase activity, cells were harvested using reporter
lysis buffer (Promega) and luciferase activity was then assessed via
luminometry. The value of luciferase activity was normalized to
transfection efficiency monitored by the co-transfected b-galacto-
sidase expression vector.
Fluorescence microscopy
Macrophages (56105) were plated onto 18 mm2 coverslips kept
in 30 mm petri plates and cultured overnight. The cells were then
incubated with L. donovani promastigotes, both alone or in
combination with GRA (20 mM) for 3 h, washed twice in PBS,
and fixed with methanol for 15 min at room temperature. After
fixation the cells were permeablized with 0.1% Triton X and
incubated with NF-kB p65 antibody for 1 h at 4uC. After washing,
coverslips were incubated with allophycocyanin (APC)-conjugated
secondary antibody (1 h, 4uC). The cells were then stained with
DAPI (49,6-diamidino-2-phenylindole, 1 mg/ml) in PBS plus
10 mg/ml Rnase A to label the nucleus, mounted on slides and
visualized under Olympus BX61 microscope at a magnification of
1000 and the images thus captured were processed using
ImagePro Plus (Media Cybernetics).
PTP activity assay
PTP activity was measured using PTP Assay kit (Sigma-Aldrich)
as described earlier [27]. Briefly, infected and GRA-treated
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BMDM were lysed in lysis buffer (50 mM Hepes, pH 7.4,
containing 0.5% Triton X-100, 10% glycerol, 1 mM benzami-
dine, 10 mg/ml aprotinin, 10 mg/ml leupeptin, and 2 mg/ml
pepstatin A), incubated on ice for 30 min and centrifuged at
10,0006 g for 15 min at 4uC. Protein content was determined in
cleared lysate by Bio-Rad protein assay. 10 mg of protein extract
were used to measure PTP activity using monophosphorylated
phosphotyrosine peptide as substrate. Free inorganic phosphate
was detected with malachite green (Sigma-Aldrich), and OD was
taken at 620 nm.
Ex vivo phosphatase assay
Enzyme activity for MKP1, MKP3 and PP2A were determined
from isolated splenocytes as described previously [27]. Briefly,
MKP1 and MKP3 were immunoprecipitated from 300 mg of the
whole cell lysate using 2 mg of anti-MKP1 or anti-MKP3 antibody
and 100 ml of protein A-Sepharose (Santa Cruz Biotechnology) at
4uC for 2 h. Immune complexes were collected, washed 4 times
and finally resuspended in 100 ml lysis buffer. The assay was
performed in phosphatases assay buffer at 37uC for 30 min.
Reactions were terminated by addition of 50 ml of 200 mM
NaOH and absorbance was taken at 410 nm. PP2A activity was
determined as described previously [27] by using the Serine/
Threonine Phosphatase Assay System from Promega.
MAPK dephosphorylation assay
For MAPK dephosphorylation assay, whole cell protein was
obtained by lysing the cells in lysis buffer [50 mM Tris-HCl,
pH 7.4, 150 mM NaCl, 1% NP-40 and complete protease
inhibitors (Roche Applied Science)]. Immunoprecipitation was
performed by incubation of cell lysate (500 mg/500 ml) with 5 mg
of respective antibodies (anti SHP-1, anti-MKP1, anti-MKP3 or
anti-PP2A) and rocked overnight at 4uC. 50 ml/sample protein G
plus-agarose (Santa Cruz Biotechnology) was added and rocking
was allowed to continue for another 1 h. The immunoprecipitates
were washed twice with lysis buffer and once with phosphatase
buffer (50 mM Tris-HCl, pH 7.5, 1 mM MgCl2, 0.1 mM EDTA
and 100 mg/ml bovine serum albumin, 50 mg/ml leupeptin) in
non-reducing conditions without b-mercaptoethanol. Immuno-
precipitated phosphatases were incubated with 0.1 mg of recom-
binant p-ERK (Stratagene) or 0.25 mg of recombinant p-p38 [43]
at 37uC in phosphatase buffer [27]. The reaction was terminated
by adding 26 sample buffer. The samples were separated on a
SDS-PAGE and blotted with p-ERK or p-p38 antibody.
Statistical analysis
Data shown are representative of at least three independent
experiments unless otherwise stated as n values given in the legend.
Macrophage cultures were set in triplicates and the results are
expressed as the mean 6 SD. Student’s t test was employed to
assess the statistical significances of differences among pair of data
sets with a p value,0.05 considered to be significant.
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